Andre Yarham, from Dereham in Norfolk, United Kingdom, died on 27 December 2025 after a rapid decline caused by frontotemporal dementia (FTD), a degenerative brain disease that usually affects people between the ages of 45 and 65. His family agreed to donate his brain to researchers at Addenbrooke’s Hospital in Cambridge in the hope that it could help scientists better understand the illness and develop future treatments.

 

Yarham was only 22 when his mother, Samantha Fairbairn, first noticed troubling changes in his behaviour. He began forgetting things and acting out of character, prompting medical tests that revealed unusual shrinkage in his brain. Doctors later diagnosed him with frontotemporal dementia, a rare condition linked to abnormal protein build-up that damages brain cells.

 

The disease progressed quickly. Within months, Yarham required full-time care and eventually lost his ability to speak. In the final stages of the illness, he relied on a wheelchair and needed help with daily tasks such as eating.

 

Following his death, doctors carried out the brain donation procedure in which his brain tissue was preserved and transferred to research facilities at Addenbrooke’s Hospital. Scientists will now examine the tissue to study how frontotemporal dementia develops and progresses, and to search for biological clues that could lead to earlier diagnosis or more effective treatments.

 

Researchers say brain donations are essential for studying neurological conditions because they allow scientists to analyse damaged tissue directly, helping them understand the molecular changes behind diseases such as dementia.

 

Yarham’s family say the donation reflects his compassionate nature and their hope that his story could help other families in the future.

 

“If in the future that can help one family get a few more years with their loved one, then that would be worth it,” his mother told the BBC.

 

Medical experts say donations like Yarham’s could play a crucial role in improving treatments and potentially slowing the effects of dementia, a disease that currently has no cure.

 

His family hopes that his legacy will raise awareness that dementia can affect younger people and inspire others to consider donating tissue to support scientific research.